Antibodies/Critical Reagents Program
Antigens/Critical Reagents Program
Assays/Panels
Cell Banks
Clones
|
NR-8273
|
Yeast 2 Hybrid Clone, 15226276, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8274
|
BPRC Yeast 2 Hybrid Clone, 15226279, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8275
|
BPRC Yeast 2 Hybrid Clone, 15226285, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8276
|
BPRC Yeast 2 Hybrid Clone, 15226287, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8277
|
BPRC Yeast 2 Hybrid Clone, 15226289, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8278
|
BPRC Yeast 2 Hybrid Clone, 15226293, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8279
|
BPRC Yeast 2 Hybrid Clone, 15226294, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8280
|
BPRC Yeast 2 Hybrid Clone, 15226295, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8281
|
BPRC Yeast 2 Hybrid Clone, 15226301, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8282
|
BPRC Yeast 2 Hybrid Clone, 15226307, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8283
|
BPRC Yeast 2 Hybrid Clone, 15226315, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8284
|
BPRC Yeast 2 Hybrid Clone, 15226328, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8285
|
BPRC Yeast 2 Hybrid Clone, 15226337, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8286
|
BPRC Yeast 2 Hybrid Clone, 15226339, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8287
|
BPRC Yeast 2 Hybrid Clone, 15226353, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8288
|
BPRC Yeast 2 Hybrid Clone, 15226362, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8289
|
BPRC Yeast 2 Hybrid Clone, 15226368, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8290
|
BPRC Yeast 2 Hybrid Clone, 15226179, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8291
|
BPRC Yeast 2 Hybrid Clone, 15226181, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-8292
|
BPRC Yeast 2 Hybrid Clone, 15226185, Vaccinia virus
|
Vaccinia virus
|
BEI Level 1
|
Genomic Materials/Critical Reagents Program
Monoclonal Antibodies
|
MRA-28
|
Anti-Pfs 25 mAb 4B7
|
Plasmodium falciparum
|
BEI Level 1
|
|
NR-417
|
Monoclonal Anti-Vaccinia (WR) L1R, Residues 1 to 185 (similar to VMC-2), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-418
|
Monoclonal Anti-Vaccinia (WR) L1R, Residues 1 to 185 (similar to VMC-3), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-419
|
Monoclonal Anti-Vaccinia (WR) L1R, Residues 1 to 185 (similar to VMC-4), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-420
|
Monoclonal Anti-Vaccinia (WR) L1R, Residues 1 to 185 (similar to VMC-5), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-421
|
Monoclonal Anti-Vaccinia (WR) L1R, Residues 1 to 185 (similar to VMC-6), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-422
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-7)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-423
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-8), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-424
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-9), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-426
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-11), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-427
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-12), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-428
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-13), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-429
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-14), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-430
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-15), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-431
|
Monoclonal Anti-Vaccinia (WR) B5R, Residues 20 to 275, Ectodomain (similar to VMC-16), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-551
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-20), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-552
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-21), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-553
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-22), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-554
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-23), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-555
|
Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-24), (produced in vitro)
|
Vaccinia virus
|
BEI Level 1
|
Nucleic Acids
|
NR-2634
|
Genomic DNA from Vaccinia Virus, Modified Vaccinia Ankara (MVA)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2635
|
Genomic DNA from Vaccinia Virus, Lister (Elstree)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2636
|
Genomic DNA from Vaccinia Virus, IHD
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2637
|
Genomic DNA from Vaccinia Virus, Lederle-Chorioallantoic
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2638
|
Genomic DNA from Vaccinia Virus, New York City Board of Health (Wyeth, Calf adapted)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2639
|
Genomic DNA from Vaccinia Virus, Western Reserve (NIAID, Tissue culture adapted)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2640
|
Genomic DNA from Vaccinia Virus, Western Reserve (Mouse adapted)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2641
|
Genomic DNA from Cowpox Virus, Brighton Red
|
Cowpox virus
|
BEI Level 1
|
|
NR-3071
|
Genomic DNA from Monkeypox Virus, WRAIR 7-61
|
Monkeypox virus
|
BEI Level 1
|
|
NR-4928
|
Genomic DNA from Monkeypox Virus, USA-2003
|
Monkeypox virus
|
BEI Level 1
|
Peptide Arrays
Plasmid/Vectors
Polyclonal Antiserum
|
NR-627
|
Polyclonal Anti-Vaccinia Virus (WR) A27L Protein, (antiserum, Rabbit)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-628
|
Polyclonal Anti-Vaccinia Virus (WR) A33R Protein, (antiserum, Rabbit)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-629
|
Polyclonal Anti-Vaccinia Virus (WR) B5R Protein, (antiserum, Rabbit)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-630
|
Polyclonal Anti-Vaccinia Virus (WR) F9L Protein, (antiserum, Rabbit)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-631
|
Polyclonal Anti-Vaccinia Virus (WR) L1R Protein, (antiserum, Rabbit)
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2632
|
Polyclonal Anti-Vaccinia Virus (immune globulin G, Human)
|
Vaccinia virus
|
BEI Level 1
|
Primers and Probes
Proteins
|
NR-545
|
(WR) A33R Protein with C-terminal Histidine Tag, Recombinant from baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-546
|
(WR) B5R Protein with N-terminal Histidine Tag, Recombinant from baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2622
|
(WR) A27L Protein with C-terminal Histidine Tag, Recombinant from Baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2623
|
(WR) A33R Protein with C-terminal Histidine Tag, Recombinant from baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2624
|
(WR) B5R Protein with N-terminal Histidine Tag, Recombinant from baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2625
|
(WR) L1R Protein with C-terminal Histidine Tag, Recombinant from baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-2626
|
(WR) F9L Protein with C-terminal Histidine Tag, Recombinant from baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-10501
|
Variola Major Virus (Bangladesh-1975) M1R Protein, Recombinant from Baculovirus (Homolog of Vaccinia Virus L1R)
|
Variola major virus
|
BEI Level 1
|
|
NR-10502
|
Variola Major Virus (Bangladesh-1975) B6R Protein, Recombinant from Baculovirus (Homolog of Vaccinia Virus B5R)
|
Variola major virus
|
BEI Level 1
|
|
NR-10503
|
Variola Major Virus (India-1967) A36R Protein, Recombinant from Baculovirus (Homolog of Vaccinia Virus A33R)
|
Variola major virus
|
BEI Level 1
|
|
NR-21986
|
(WR) L1R Protein with C-Terminal Histidine Tag, Recombinant from Baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-22132
|
(WR) B5R Protein with N-Terminal Histidine Tag, Recombinant from Baculovirus
|
Vaccinia virus
|
BEI Level 1
|
|
NR-22133
|
(WR) A27L Protein with C-Terminal Histidine Tag, Recombinant from Baculovirus
|
Vaccinia virus
|
BEI Level 1
|
Viruses
|
NR-1
|
Vaccinia virus
|
Modified Vaccinia Ankara (MVA)
|
BEI Level 2
|
|
NR-27
|
Monkeypox virus
|
WRAIR 7-61
|
BEI Level 3
|
|
NR-51
|
Vaccinia virus
|
Lister (Elstree)
|
BEI Level 2
|
|
NR-52
|
Vaccinia virus
|
IHD
|
BEI Level 2
|
|
NR-53
|
Vaccinia virus
|
Lederle-Chorioallantoic
|
BEI Level 2
|
|
NR-54
|
Vaccinia virus
|
New York City Board of Health (Wyeth, Calf adapted)
|
BEI Level 2
|
|
NR-55
|
Vaccinia virus
|
Western Reserve (NIAID, Tissue culture adapted)
|
BEI Level 2
|
|
NR-56
|
Vaccinia virus
|
Western Reserve (Mouse adapted)
|
BEI Level 2
|
|
NR-88
|
Cowpox virus
|
Brighton Red
|
BEI Level 2
|
|
NR-623
|
Vaccinia virus
|
MVA/S, Recombinant Expressing SARS CoV Spike (S) Protein
|
BEI Level 2
|
|
NR-624
|
Vaccinia virus
|
VV.NP-S-EGFP, Recombinant Expressing Enhanced Green Fluorescent Protein
|
BEI Level 2
|
|
NR-726
|
Vaccinia virus
|
Modified Vaccinia Ankara (MVA), From BHK-21 Cells
|
BEI Level 2
|
|
NR-727
|
Vaccinia virus
|
Modified Vaccinia Ankara (MVA), From BHK-21 Cells, Purified
|
BEI Level 2
|
|
NR-793
|
Vaccinia virus
|
vSC56, Recombinant Expressing Beta-Galactosidase
|
BEI Level 2
|
|
NR-2324
|
Monkeypox virus
|
Zaire 79 (V79-I-005)
|
BEI Level 3
|
|
NR-2500
|
Monkeypox virus
|
USA-2003
|
BEI Level 3
|
|
NR-9597
|
Cowpox virus
|
Brighton Red Recombinant Expressing Enhanced Green Fluorescent Protein
|
BEI Level 2
|
|
NR-15494
|
Lassa virus
|
Vaccinia Virus, Recombinant Expressing Lassa Virus, Josiah L Protein
|
BEI Level 2
|
|
NR-15495
|
Lassa virus
|
Vaccinia Virus, Western Reserve, Recombinant Expressing Lassa Virus, Josiah Nucleoprotein
|
BEI Level 2
|
|
NR-15496
|
Lassa virus
|
Vaccinia Virus, Recombinant Expressing Lassa Virus, Josiah Z Protein
|
BEI Level 2
|
|